| Leistung |
Fallzahl |
OPS-Schlüssel |
Info |
|
9.949
|
9-649.40 |
|
|
7.213
|
9-649.31 |
|
|
5.772
|
9-649.20 |
|
| Psychotherapeutische Komplexbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Erwachsenen |
5.147
|
9-626 |
|
|
5.039
|
9-649.41 |
|
| Regelbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Erwachsenen |
4.334
|
9-607 |
|
|
2.916
|
9-649.33 |
|
|
2.640
|
9-649.50 |
|
|
2.405
|
9-649.30 |
|
|
1.525
|
9-649.32 |
|
|
1.270
|
9-649.51 |
|
|
1.022
|
9-649.42 |
|
|
989
|
9-649.10 |
|
|
868
|
9-649.11 |
|
|
667
|
9-649.21 |
|
|
468
|
9-649.35 |
|
|
431
|
9-649.52 |
|
|
392
|
9-649.34 |
|
|
309
|
9-649.13 |
|
|
279
|
9-649.0 |
|
|
195
|
9-649.53 |
|
|
183
|
9-649.12 |
|
|
173
|
9-649.37 |
|
|
170
|
9-696.20 |
|
|
163
|
9-649.43 |
|
|
122
|
9-696.10 |
|
|
106
|
9-696.42 |
|
|
79
|
9-649.54 |
|
|
76
|
9-696.41 |
|
|
74
|
9-696.21 |
|
|
73
|
9-696.43 |
|
|
65
|
9-649.36 |
|
|
54
|
9-649.22 |
|
|
53
|
9-649.44 |
|
|
51
|
9-649.15 |
|
|
41
|
9-649.39 |
|
|
40
|
9-649.55 |
|
|
38
|
9-649.14 |
|
|
35
|
9-696.33 |
|
|
35
|
9-696.34 |
|
| Regelbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Kindern und Jugendlichen |
34
|
9-656 |
|
|
34
|
9-696.37 |
|
|
32
|
9-696.35 |
|
|
28
|
9-696.11 |
|
|
28
|
9-696.44 |
|
|
27
|
9-696.32 |
|
|
25
|
9-696.36 |
|
|
23
|
9-696.22 |
|
|
22
|
9-696.40 |
|
|
19
|
9-696.38 |
|
|
18
|
9-696.3b |
|
|
17
|
9-649.56 |
|
|
13
|
9-696.17 |
|
|
13
|
9-696.3a |
|
|
12
|
9-649.38 |
|
|
12
|
9-649.45 |
|
|
12
|
9-696.39 |
|
|
12
|
9-696.45 |
|
|
11
|
9-649.23 |
|
|
11
|
9-696.13 |
|
|
10
|
9-696.14 |
|
|
10
|
9-696.31 |
|
|
10
|
9-696.51 |
|
|
9
|
9-696.50 |
|
|
8
|
9-696.16 |
|
|
7
|
9-696.12 |
|
|
7
|
9-696.19 |
|
|
6
|
9-696.30 |
|
|
6
|
9-696.52 |
|
|
5
|
9-649.3b |
|
|
5
|
9-696.18 |
|
|
5
|
9-696.24 |
|
|
5
|
9-696.3e |
|
|
5
|
9-696.53 |
|
|
4
|
9-649.57 |
|
|
4
|
9-696.15 |
|
|
4
|
9-696.23 |
|
|
4
|
9-696.3c |
|
|
4
|
9-696.3d |
|
| Applikation von Medikamenten, Liste 1: Adalimumab, parenteral: 80 mg bis unter 120 mg 80 mg bis unter 120 mg |
k.A.
|
6-001.d3 |
|
| Applikation von Medikamenten, Liste 3: Abatacept, intravenös: 1.000 mg bis unter 1.250 mg 1.000 mg bis unter 1.250 mg |
k.A.
|
6-003.s4 |
|
| Applikation von Medikamenten, Liste 5: Golimumab, parenteral |
k.A.
|
6-005.2 |
|
|
k.A.
|
9-649.16 |
|
|
k.A.
|
9-649.17 |
|
|
k.A.
|
9-649.1g |
|
|
k.A.
|
9-649.24 |
|
|
k.A.
|
9-649.3a |
|
|
k.A.
|
9-649.3d |
|
|
k.A.
|
9-649.3f |
|
|
k.A.
|
9-649.46 |
|
|
k.A.
|
9-649.47 |
|
|
k.A.
|
9-649.48 |
|
|
k.A.
|
9-649.5a |
|
|
k.A.
|
9-696.1a |
|
|
k.A.
|
9-696.1b |
|
|
k.A.
|
9-696.1c |
|
|
k.A.
|
9-696.1d |
|
|
k.A.
|
9-696.1e |
|
|
k.A.
|
9-696.1g |
|
|
k.A.
|
9-696.25 |
|
|
k.A.
|
9-696.3f |
|
|
k.A.
|
9-696.3g |
|
|
k.A.
|
9-696.46 |
|
|
k.A.
|
9-696.47 |
|
|
k.A.
|
9-696.48 |
|
|
k.A.
|
9-696.49 |
|
|
k.A.
|
9-696.54 |
|
|
k.A.
|
9-984.8 |
|
